https://doi.org/10.4081/reumatismo.2019.1104
Pain and quality of life in knee osteoarthritis, chronic low back pain and fibromyalgia: a comparative cross-sectional study
Accepted: 15 April 2019
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The objective of our study was to compare pain and health-related quality of life among patients with knee osteoarthritis (OA), chronic nonspecific low back pain (CNLBP) and fibromyalgia (FM). This cross-sectional study included 87 subjects, who were divided into three groups according to their diagnosis: knee OA (n=29), CNLBP (n=29) and FM (n=29), between March 2013 and March 2014. Pain intensity was measured using the Numeric Pain Rating Scale (NPRS), quality of pain using the McGill Pain Questionnaire (MPQ) and health-related quality of life using the 36-item Short-Form Health Survey (SF-36). Painful body areas were marked on a pain map. No statistically significant differences between groups were found for NPRS. Regarding MPQ, the knee OA group presented a lower pain-rating index in contrast to the CNLBP and FM groups, and no significant differences were found between the CNLBP and FM groups. A greater number of characteristic pain descriptors and painful locations were found in the FM group than in the CNLBP or knee OA groups. Regarding SF-36, the FM group presented statistically significant lower values for bodily pain in contrast to the knee OA group. Even though the global pain intensity was similar between groups, the findings suggest that the FM group presented the worst pain experience and a lower health-related quality of life than the knee OA group in terms of bodily pain. They also suggest that the pain experience was worse for the CNLBP group than for the knee OA group but health-related quality of life was similar.
How to Cite
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- W. Grassi, R. De Angelis, Clinical features of gout , Reumatismo: Vol. 63 No. 4 (2011): Special issue • Microcrystalline Arthritis
- A. Marchesoni, F. Cantini, Classification and clinical assessment , Reumatismo: Vol. 64 No. 2 (2012)
- F. Muratore, C. Salvarani, P. Macchioni, Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica , Reumatismo: Vol. 70 No. 1 (2018): Monographic issue on Polymyalgia Rheumatica
- F.M. Perrotta, A. Delle Sedie, S. Scriffignano, P. Volpe, E. Cordisco, N. Milano, M. Gabini, E. Lubrano, Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study , Reumatismo: Vol. 72 No. 1 (2020)
- P. Sarzi- Puttini, R. Torta, F. Marinangeli, G. Biasi, M. Spath, D. Buskila, R.H. Gracely, M.A. Giamberardino, L. Bazzichi, M. Cazzola, M. Di Franco, S. Stisi, F. Salaffi, R. Casale, G. Leardini, R. Gorla, A. Marsico, R. Carignola, L. Altomonte, F. Ceccherelli, G. Cassisi, G. Arioli, A. Alciati, F. Atzeni, Fibromyalgia syndrome: the pharmacological treatment options , Reumatismo: Vol. 60 No. s1 (2008)
- S. D'Angelo, C. Palazzi, I. Olivieri, Psoriatic arthritis: treatment strategies using biologic agents , Reumatismo: Vol. 64 No. 2 (2012)
- M. Benucci, A. Damiani, A. Arena, M. Infantino, M. Manfredi, F. Li Gobbi, Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment , Reumatismo: Vol. 68 No. 3 (2016)
- R. Cossutta, S. Zeni, A. Soldi, P. Colombelli, A. Belotti Masserini, F. Fantini, Evaluation of quality of life in patients with systemic sclerosis by the SF-36 questionnaire , Reumatismo: Vol. 54 No. 2 (2002)
- E. Catarsi, M. Doveri, A. Tavoni, Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers , Reumatismo: Vol. 65 No. 2 (2013)
- F. Cassalia, A. Belloni Fortina, Psoriasis in women with psoriatic arthritis: hormonal effects, fertility, and considerations for management at different stages of life , Reumatismo: Vol. 76 No. 3 (2024)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
You may also start an advanced similarity search for this article.
